UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy

The American journal of cardiology, 2016-06, Vol.117 (12), p.1928-1933

2016

Volltextzugriff (PDF)

Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia

Journal of the American College of Cardiology, 2013-09, Vol.62 (13), p.1154-1162

2013

Volltextzugriff (PDF)

Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance

Journal of clinical lipidology, 2015-05, Vol.9 (3), p.295-304

2015

Volltextzugriff (PDF)

Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance

Journal of clinical lipidology, 2016-05, Vol.10 (3), p.556-567

2016

Volltextzugriff (PDF)

Absence of effect of steady state bempedoic acid on cardiac repolarization: Results of a thorough QT/QTc study in healthy volunteers

Clinical and translational science, 2021-11, Vol.14 (6), p.2487-2496

2021

Volltextzugriff (PDF)

Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial

Atherosclerosis, 2021-03, Vol.320, p.122-128

2021

Volltextzugriff (PDF)

Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial

Journal of the American College of Cardiology, 2013-09, Vol.62 (13), p.1154-1162

2013

Volltextzugriff (PDF)

Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial

Journal of clinical lipidology, 2021-07, Vol.15 (4), p.593-601

2021

Volltextzugriff (PDF)

Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus

Arteriosclerosis, thrombosis, and vascular biology, 2014-03, Vol.34 (3), p.676-683

2014

Volltextzugriff (PDF)

Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial

Journal of clinical lipidology, 2019-07, Vol.13 (4), p.568-579

2019

Volltextzugriff (PDF)

Trends in Patient Access to and Utilization of Prescribed PCSK9 Inhibitors in a Large US Claims Database From 2015 to 2021

Circulation Cardiovascular quality and outcomes, 2024-02, Vol.17 (2)

2024

Volltextzugriff (PDF)

Phase 1, Single- and Multiple-Ascending-Dose, Food-Effect, and East Asian Subject Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Bempedoic Acid, a Selective Inhibitor of Adenosine Triphosphate Citrate Lyase

Clinical pharmacology in drug development, 2023-10, Vol.12 (10), p.1022-1035

2023

Volltextzugriff (PDF)

DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA: A WORK IN PROGRESS

American journal of preventive cardiology, 2023-03, Vol.13, p.100414, Article 100414

2023

Volltextzugriff (PDF)

Phytosterols partially explain differences in cholesterol metabolism caused by corn or olive oil feeding

Journal of lipid research, 1998-04, Vol.39 (4), p.892-900

1998

Volltextzugriff (PDF)

Medium chain fatty acid metabolism and energy expenditure: Obesity treatment implications

Life Sciences, 1998, Vol.62 (14), p.1203-1215

1998

Volltextzugriff (PDF)

Dietary phytosterols as cholesterol-lowering agents in humans

Canadian journal of physiology and pharmacology, 1997-03, Vol.75 (3), p.217-227

1997

Volltextzugriff (PDF)

Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset

Metabolism, clinical and experimental, 2023-05, Vol.142, p.155497, Article 155497

2023

Volltextzugriff (PDF)

Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol

The American journal of cardiology, 2003-09, Vol.92 (5), p.538-543

2003

Volltextzugriff (PDF)

ETC-1002 Reduces Blood Pressure in Hypercholesterolemic Patients with Mildly Elevated Blood Pressure

Journal of clinical lipidology, 2014-05, Vol.8 (3), p.350-350

2014

Volltextzugriff (PDF)

Using Healthcare Claims Data and Machine Learning to Identify Health Disparities for Individuals with Diagnosed and Undiagnosed Familial Hypercholesterolemia

Metabolism, clinical and experimental, 2023-05, Vol.142, p.155496, Article 155496

2023

Volltextzugriff (PDF)

Abstract 17499: ETC-1002 Incrementally Lowers Low Density Lipoprotein-cholesterol in Patients With Hypercholesterolemia Receiving Stable Statin Therapy

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A17499-A17499

2015

Volltextzugriff (PDF)

Gender effects of tall oil versus soybean phytosterols as cholesterol-lowering agents in hamsters

Canadian journal of physiology and pharmacology, 1998-07, Vol.76 (7-8), p.780-787

1998

Volltextzugriff (PDF)

Effect of butter compared with tallow consumption on postprandial oxidation of myristic and palmitic acids

The American journal of clinical nutrition, 1996-06, Vol.63 (6), p.918-924

1996

Volltextzugriff (PDF)

Short-term administration of tall oil phytosterols improves plasma lipid profiles in subjects with different cholesterol levels

Metabolism, clinical and experimental, 1998-06, Vol.47 (6), p.751-756

1998

Volltextzugriff (PDF)

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy

European journal of preventive cardiology, 2020-04, Vol.27 (6), p.593-603

2020

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(15)
Male
(15)
Female
(14)
Middle Aged
(10)
Adult
(8)
Aged
(8)
Biological And Medical Sciences
(8)
Cholesterol, Ldl - Blood
(8)
Double-Blind Method
(8)
Hypercholesterolemia
(8)
Hypercholesterolemia - Drug Therapy
(8)
Cardiovascular System & Cardiology
(7)
Cholesterol
(7)
Cardiac & Cardiovascular Systems
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Hypercholesterolemia - Blood
(6)
Pharmacology & Pharmacy
(6)
Cardiovascular
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy

Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia

Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance

Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance

Absence of effect of steady state bempedoic acid on cardiac repolarization: Results of a thorough QT/QTc study in healthy volunteers

Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial

Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial

Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial

Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus

Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial

Trends in Patient Access to and Utilization of Prescribed PCSK9 Inhibitors in a Large US Claims Database From 2015 to 2021

Phase 1, Single- and Multiple-Ascending-Dose, Food-Effect, and East Asian Subject Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Bempedoic Acid, a Selective Inhibitor of Adenosine Triphosphate Citrate Lyase

DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA: A WORK IN PROGRESS

Phytosterols partially explain differences in cholesterol metabolism caused by corn or olive oil feeding

Medium chain fatty acid metabolism and energy expenditure: Obesity treatment implications

Dietary phytosterols as cholesterol-lowering agents in humans

Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset

Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol

ETC-1002 Reduces Blood Pressure in Hypercholesterolemic Patients with Mildly Elevated Blood Pressure

Using Healthcare Claims Data and Machine Learning to Identify Health Disparities for Individuals with Diagnosed and Undiagnosed Familial Hypercholesterolemia

Abstract 17499: ETC-1002 Incrementally Lowers Low Density Lipoprotein-cholesterol in Patients With Hypercholesterolemia Receiving Stable Statin Therapy

Gender effects of tall oil versus soybean phytosterols as cholesterol-lowering agents in hamsters

Effect of butter compared with tallow consumption on postprandial oxidation of myristic and palmitic acids

Short-term administration of tall oil phytosterols improves plasma lipid profiles in subjects with different cholesterol levels

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy

Suchergebnisse filtern